Skip to content
Home › 13F recaps › Q3 2026 › TXG

Which funds bought or sold TXG in Q3 2026?

10X Genomics Inc. 2 funds bought, 6 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$236M. See also what famous investors say about TXG.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold TXG, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (2)

FundChangeEst. $Now
Viking
Hedge fund
New+$68M$68M
Maverick
Hedge fund
New+$49M$49M

Sold (6)

FundChangeEst. $Now
ARK
Growth / crossover
Trimmed-37.3%−$337M$567M
Citadel
Quant & multi-strategy
Trimmed-99.4%−$250M$1M
Point72
Quant & multi-strategy
Trimmed-96%−$161M$7M
Vanguard
Index giant
Trimmed-15.3%−$96M$534M
Renaissance
Quant & multi-strategy
Trimmed-91.8%−$66M$6M
Duquesne
Family office & foundation
Sold out−$15M—

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.